{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T04:23:48Z","timestamp":1792988628841,"version":"4.5.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,13]],"date-time":"2025-01-13T00:00:00Z","timestamp":1736726400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,13]],"date-time":"2025-01-13T00:00:00Z","timestamp":1736726400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Charles Darwin University International PhD Scholarship"},{"name":"Clinical Trials and Cohort Studies grant from the National Health and Medical Research Council of Australia","award":["GNT2000780"],"award-info":[{"award-number":["GNT2000780"]}]},{"name":"Maple-Brown Family Foundation Menzies School of Health Research Future Researcher Fellowship"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"DOI":"10.1186\/s12936-024-05233-1","type":"journal-article","created":{"date-parts":[[2025,1,13]],"date-time":"2025-01-13T21:03:28Z","timestamp":1736802208000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Acceptability of intermittent preventive treatment of malaria in pregnancy with sulfadoxine-pyrimethamine plus dihydroartemisinin-piperaquine in Papua New Guinea: a qualitative study"],"prefix":"10.1186","volume":"24","author":[{"given":"Elvin","family":"Lufele","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Pascoe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Mengi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alma","family":"Auwun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nalisa","family":"Neuendorf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John W.","family":"Bolnga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moses","family":"Laman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J.","family":"Rogerson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamala","family":"Thriemer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holger W.","family":"Unger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,13]]},"reference":[{"key":"5233_CR1","doi-asserted-by":"publisher","first-page":"e40","DOI":"10.1016\/S2214-109X(22)00431-4","volume":"11","author":"V Reddy","year":"2023","unstructured":"Reddy V, Weiss DJ, Rozier J, ter Kuile FO, Dellicour S. Global estimates of the number of pregnancies at risk of malaria from 2007 to 2020: a demographic study. Lancet Glob Health. 2023;11:e40\u20137.","journal-title":"Lancet Glob Health"},{"key":"5233_CR2","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/S1473-3099(07)70021-X","volume":"7","author":"M Desai","year":"2007","unstructured":"Desai M, ter Kuile FO, Nosten F, McGready R, Asamoa K, Brabin B, et al. Epidemiology and burden of malaria in pregnancy. Lancet Infect Dis. 2007;7:93\u2013104.","journal-title":"Lancet Infect Dis"},{"key":"5233_CR3","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.placenta.2003.10.019","volume":"25","author":"BJ Brabin","year":"2004","unstructured":"Brabin BJ, Romagosa C, Abdelgalil S, Menendez C, Verhoeff FH, McGready R, et al. The sick placenta-the role of malaria. Placenta. 2004;25:359\u201378.","journal-title":"Placenta"},{"key":"5233_CR4","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1093\/cid\/cis236","volume":"54","author":"A Mayor","year":"2012","unstructured":"Mayor A, Moro L, Aguilar R, Bardaj\u00ed A, Cister\u00f3 P, Serra-Casas E, et al. How hidden can malaria be in pregnant women? Diagnosis by microscopy, placental histology, polymerase chain reaction and detection of histidine-rich protein 2 in plasma. Clin Infect Dis. 2012;54:1561\u20138.","journal-title":"Clin Infect Dis"},{"key":"5233_CR5","doi-asserted-by":"publisher","first-page":"e107","DOI":"10.1016\/S1473-3099(18)30066-5","volume":"18","author":"SJ Rogerson","year":"2018","unstructured":"Rogerson SJ, Desai M, Mayor A, Sicuri E, Taylor SM, van Eijk AM. Burden, pathology, and costs of malaria in pregnancy: new developments for an old problem. Lancet Infect Dis. 2018;18:e107\u201318.","journal-title":"Lancet Infect Dis"},{"key":"5233_CR6","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/S1473-3099(07)70022-1","volume":"7","author":"SJ Rogerson","year":"2007","unstructured":"Rogerson SJ, Hviid L, Duffy PE, Leke RF, Taylor DW. Malaria in pregnancy: pathogenesis and immunity. Lancet Infect Dis. 2007;7:105\u201317.","journal-title":"Lancet Infect Dis"},{"key":"5233_CR7","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1186\/1475-2875-10-321","volume":"10","author":"JH Kattenberg","year":"2011","unstructured":"Kattenberg JH, Ochodo EA, Boer KR, Schallig HD, Mens PF, Leeflang MM. Systematic review and meta-analysis: rapid diagnostic tests versus placental histology, microscopy and PCR for malaria in pregnant women. Malar J. 2011;10:321.","journal-title":"Malar J"},{"key":"5233_CR8","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1186\/s12936-015-0927-5","volume":"14","author":"AJ Umbers","year":"2015","unstructured":"Umbers AJ, Unger HW, Rosanas-Urgell A, Wangnapi RA, Kattenberg JH, Jally S, et al. Accuracy of an HRP-2\/panLDH rapid diagnostic test to detect peripheral and placental Plasmodium falciparum infection in Papua New Guinean women with anaemia or suspected malaria. Malar J. 2015;14:412.","journal-title":"Malar J"},{"key":"5233_CR9","unstructured":"WHO. Policy brief for the implementation of intermittent preventive treatment of malaria in pregnancy using sulfadoxine-pyrimethamine (IPTp-SP). Geneva, World Health Organization, 2013. Available from: https:\/\/www.who.int\/publications\/i\/item\/WHO-HTM-GMP-2014.4 [accessed 1 July 2024]."},{"key":"5233_CR10","unstructured":"WHO. Guidelines for malaria. Geneva, World Health Organization, 2023. Available from: https:\/\/iris.who.int\/handle\/10665\/373339 [accessed 21 July 2024]."},{"key":"5233_CR11","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1016\/S1473-3099(12)70222-0","volume":"12","author":"TP Eisele","year":"2012","unstructured":"Eisele TP, Larsen DA, Anglewicz PA, Keating J, Yukich J, Bennett A, et al. Malaria prevention in pregnancy, birthweight, and neonatal mortality: a meta-analysis of 32 national cross-sectional datasets in Africa. Lancet Infect Dis. 2012;12:942\u20139.","journal-title":"Lancet Infect Dis"},{"key":"5233_CR12","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1001\/jama.2012.216231","volume":"309","author":"K Kayentao","year":"2013","unstructured":"Kayentao K, Garner P, van Eijk AM, Naidoo I, Roper C, Mulokozi A, et al. Intermittent preventive therapy for malaria during pregnancy using 2 vs 3 or more doses of sulfadoxine-pyrimethamine and risk of low birth weight in Africa: systematic review and meta-analysis. JAMA. 2013;309:594\u2013604.","journal-title":"JAMA"},{"key":"5233_CR13","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1093\/cid\/civ881","volume":"62","author":"M Desai","year":"2016","unstructured":"Desai M, Gutman J, Taylor SM, Wiegand RE, Khairallah C, Kayentao K, et al. Impact of Sulfadoxine-pyrimethamine resistance on effectiveness of intermittent preventive therapy for malaria in pregnancy at clearing infections and preventing low birth weight. Clin Infect Dis. 2016;62:323\u201333.","journal-title":"Clin Infect Dis"},{"key":"5233_CR14","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.pt.2013.08.002","volume":"29","author":"I Naidoo","year":"2013","unstructured":"Naidoo I, Roper C. Mapping \u2018partially resistant\u2019, \u2018fully resistant\u2019, and \u2018super resistant\u2019 malaria. Trends Parasitol. 2013;29:505\u201315.","journal-title":"Trends Parasitol"},{"key":"5233_CR15","doi-asserted-by":"publisher","first-page":"e119","DOI":"10.1016\/S1473-3099(18)30064-1","volume":"18","author":"M Desai","year":"2018","unstructured":"Desai M, Hill J, Fernandes S, Walker P, Pell C, Gutman J, et al. Prevention of malaria in pregnancy. Lancet Infect Dis. 2018;18:e119\u201332.","journal-title":"Lancet Infect Dis"},{"key":"5233_CR16","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/S1473-3099(18)30732-1","volume":"19","author":"AM van Eijk","year":"2019","unstructured":"van Eijk AM, Larsen DA, Kayentao K, Koshy G, Slaughter DEC, Roper C, et al. Effect of Plasmodium falciparum sulfadoxine-pyrimethamine resistance on the effectiveness of intermittent preventive therapy for malaria in pregnancy in Africa: a systematic review and meta-analysis. Lancet Infect Dis. 2019;19:546\u201356.","journal-title":"Lancet Infect Dis"},{"key":"5233_CR17","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.ijpara.2020.12.011","volume":"51","author":"R Chaturvedi","year":"2021","unstructured":"Chaturvedi R, Chhibber-Goel J, Verma I, Gopinathan S, Parvez S, Sharma A. Geographical spread and structural basis of sulfadoxine-pyrimethamine drug-resistant malaria parasites. Int J Parasitol. 2021;51:505\u201325.","journal-title":"Int J Parasitol"},{"key":"5233_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2022.966402","volume":"10","author":"SA Sundararaman","year":"2022","unstructured":"Sundararaman SA, Odom John AR. Prevention of malaria in pregnancy: the threat of sulfadoxine-pyrimethamine resistance. Front Pediatr. 2022;10: 966402.","journal-title":"Front Pediatr"},{"key":"5233_CR19","doi-asserted-by":"publisher","first-page":"e1805","DOI":"10.1016\/S2214-109X(23)00415-1","volume":"11","author":"HW Unger","year":"2023","unstructured":"Unger HW, Acharya S, Arnold L, Wu C, van Eijk AM, Gore-Langton GR, et al. The effect and control of malaria in pregnancy and lactating women in the Asia-Pacific region. Lancet Glob Health. 2023;11:e1805\u201318.","journal-title":"Lancet Glob Health"},{"key":"5233_CR20","doi-asserted-by":"publisher","first-page":"6958","DOI":"10.1128\/AAC.03323-14","volume":"58","author":"C Barnadas","year":"2014","unstructured":"Barnadas C, Senn N, Iga J, Timinao L, Javati S, Malau E, et al. Plasmodium falciparum and Plasmodium vivax genotypes and efficacy of intermittent preventive treatment in Papua New Guinea. Antimicrob Agents Chemother. 2014;58:6958\u201361.","journal-title":"Antimicrob Agents Chemother"},{"key":"5233_CR21","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s12936-015-0560-3","volume":"14","author":"T Koleala","year":"2015","unstructured":"Koleala T, Karl S, Laman M, Moore BR, Benjamin J, Barnadas C, et al. Temporal changes in Plasmodium falciparum anti-malarial drug sensitivity in vitro and resistance-associated genetic mutations in isolates from Papua New Guinea. Malar J. 2015;14:37.","journal-title":"Malar J"},{"key":"5233_CR22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001733","volume":"11","author":"R Gonzalez","year":"2014","unstructured":"Gonzalez R, Mombo-Ngoma G, Ouedraogo S, Kakolwa MA, Abdulla S, Accrombessi M, et al. Intermittent preventive treatment of malaria in pregnancy with mefloquine in HIV-negative women: a multicentre randomized controlled trial. PLoS Med. 2014;11: e1001733.","journal-title":"PLoS Med"},{"key":"5233_CR23","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1016\/S0140-6736(22)02535-1","volume":"401","author":"M Madanitsa","year":"2023","unstructured":"Madanitsa M, Barsosio CH, Minja TR, Mtove G, Kavishe AR, et al. Effect of monthly intermittent preventive treatment with dihydroartemisinin-piperaquine with and without azithromycin versus monthly sulfadoxine-pyrimethamine on adverse pregnancy outcomes in Africa: a double-blind randomised, partly placebo-controlled trial. Lancet. 2023;401:1020\u201336.","journal-title":"Lancet"},{"key":"5233_CR24","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.1016\/S0140-6736(15)00310-4","volume":"386","author":"M Desai","year":"2015","unstructured":"Desai M, Gutman J, L\u2019Lanziva A, Otieno K, Juma E, Kariuki S, et al. Intermittent screening and treatment or intermittent preventive treatment with dihydroartemisinin-piperaquine versus intermittent preventive treatment with sulfadoxine-pyrimethamine for the control of malaria during pregnancy in western Kenya: an open-label, three-group, randomised controlled superiority trial. Lancet. 2015;386:2507\u201319.","journal-title":"Lancet"},{"key":"5233_CR25","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1016\/S0140-6736(18)32224-4","volume":"393","author":"R Kajubi","year":"2019","unstructured":"Kajubi R, Ochieng T, Kakuru A, Jagannathan P, Nakalembe M, Ruel T, et al. Monthly sulfadoxine-pyrimethamine versus dihydroartemisinin-piperaquine for intermittent preventive treatment of malaria in pregnancy: a double-blind, randomised, controlled, superiority trial. Lancet. 2019;393:1428\u201339.","journal-title":"Lancet"},{"key":"5233_CR26","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1056\/NEJMoa1509150","volume":"374","author":"A Kakuru","year":"2016","unstructured":"Kakuru A, Jagannathan P, Muhindo MK, Natureeba P, Awori P, Nakalembe M, et al. Dihydroartemisinin-piperaquine for the prevention of malaria in pregnancy. N Engl J Med. 2016;374:928\u201339.","journal-title":"N Engl J Med"},{"key":"5233_CR27","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1002\/cpt.2273","volume":"110","author":"EM Mlugu","year":"2021","unstructured":"Mlugu EM, Minzi O, Kamuhabwa AAR, Aklillu E. Effectiveness of intermittent preventive treatment with dihydroartemisinin-piperaqunine against malaria in pregnancy in Tanzania: a randomized controlled trial. Clin Pharmacol Ther. 2021;110:1478\u201389.","journal-title":"Clin Pharmacol Ther"},{"key":"5233_CR28","doi-asserted-by":"publisher","first-page":"e942","DOI":"10.1016\/S2214-109X(20)30119-4","volume":"8","author":"ME Roh","year":"2020","unstructured":"Roh ME, ter Kuile FO, Rerolle F, Glymour MM, Shiboski S, Gosling R, et al. Overall, anti-malarial, and non-malarial effect of intermittent preventive treatment during pregnancy with sulfadoxine-pyrimethamine on birthweight: a mediation analysis. Lancet Glob Health. 2020;8:e942\u201353.","journal-title":"Lancet Glob Health"},{"key":"5233_CR29","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1093\/cid\/cix026","volume":"64","author":"RM Chico","year":"2017","unstructured":"Chico RM, Chaponda EB, Ariti C, Chandramohan D. Sulfadoxine-pyrimethamine exhibits dose-response protection against adverse birth outcomes related to malaria and sexually transmitted and reproductive tract infections. Clin Infect Dis. 2017;64:1043\u201351.","journal-title":"Clin Infect Dis"},{"key":"5233_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2022.103871","volume":"77","author":"A Waltmann","year":"2022","unstructured":"Waltmann A, McQuade ETR, Chinkhumba J, Operario DJ, Mzembe E, Itoh M, et al. The positive effect of malaria IPTp-SP on birthweight is mediated by gestational weight gain but modifiable by maternal carriage of enteric pathogens. EBioMedicine. 2022;77: 103871.","journal-title":"EBioMedicine"},{"key":"5233_CR31","doi-asserted-by":"publisher","first-page":"4260","DOI":"10.1128\/AAC.00326-15","volume":"59","author":"JM Benjamin","year":"2015","unstructured":"Benjamin JM, Moore BR, Salman S, Page-Sharp M, Tawat S, Yadi G, et al. Population pharmacokinetics, tolerability, and safety of dihydroartemisinin-piperaquine and sulfadoxine-pyrimethamine-piperaquine in pregnant and nonpregnant Papua New Guinean women. Antimicrob Agents Chemother. 2015;59:4260\u201371.","journal-title":"Antimicrob Agents Chemother"},{"key":"5233_CR32","doi-asserted-by":"publisher","first-page":"e01013","DOI":"10.1128\/AAC.01013-20","volume":"64","author":"E Hughes","year":"2020","unstructured":"Hughes E, Imperial M, Wallender E, Kajubi R, Huang L, Jagannathan P, et al. Piperaquine exposure is altered by pregnancy, HIV, and nutritional status in Ugandan women. Antimicrob Agents Chemother. 2020;64:e01013-e1020.","journal-title":"Antimicrob Agents Chemother"},{"key":"5233_CR33","unstructured":"National Department of Health. Papua New Guinea National Malaria Treatment Policy. 2009."},{"key":"5233_CR34","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1086\/591944","volume":"198","author":"CA Clerk","year":"2008","unstructured":"Clerk CA, Bruce J, Affipunguh PK, Mensah N, Hodgson A, Greenwood B, et al. A randomized, controlled trial of intermittent preventive treatment with sulfadoxine-pyrimethamine, amodiaquine, or the combination in pregnant women in Ghana. J Infect Dis. 2008;198:1202\u201311.","journal-title":"J Infect Dis"},{"key":"5233_CR35","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1016\/S0140-6736(06)69559-7","volume":"368","author":"H Tagbor","year":"2006","unstructured":"Tagbor H, Bruce J, Browne E, Randal A, Greenwood B, Chandramohan D. Efficacy, safety, and tolerability of amodiaquine plus sulphadoxine-pyrimethamine used alone or in combination for malaria treatment in pregnancy: a randomised trial. Lancet. 2006;368:1349\u201356.","journal-title":"Lancet"},{"key":"5233_CR36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0150259","volume":"11","author":"J Hill","year":"2016","unstructured":"Hill J, Hoyt J, Achieng F, Ouma P, L\u2019Lanziva A, Kariuki S, et al. User and provider acceptability of intermittent screening and treatment and intermittent preventive treatment with dihydroartemisinin-piperaquine to prevent malaria in pregnancy in Western Kenya. PLoS ONE. 2016;11: e0150259.","journal-title":"PLoS ONE"},{"key":"5233_CR37","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s12913-017-2031-8","volume":"17","author":"M Sekhon","year":"2017","unstructured":"Sekhon M, Cartwright M, Francis JJ. Acceptability of healthcare interventions: an overview of reviews and development of a theoretical framework. BMC Health Serv Res. 2017;17:88.","journal-title":"BMC Health Serv Res"},{"key":"5233_CR38","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/S1471-4922(03)00091-6","volume":"19","author":"I M\u00fcller","year":"2003","unstructured":"M\u00fcller I, Bockarie M, Alpers M, Smith T. The epidemiology of malaria in Papua New Guinea. Trends Parasitol. 2003;19:253\u20139.","journal-title":"Trends Parasitol"},{"key":"5233_CR39","unstructured":"WHO. World malaria report 2022. Geneva, World Health Organization, 2022. Available from: https:\/\/www.who.int\/teams\/global-malaria-programme\/reports\/world-malaria-report-2022 [accessed 22 October 2023]."},{"key":"5233_CR40","first-page":"12","volume":"51","author":"I Mueller","year":"2008","unstructured":"Mueller I, Rogerson S, Mola GD, Reeder JC. A review of the current state of malaria among pregnant women in Papua New Guinea. P N G Med J. 2008;51:12\u20136.","journal-title":"P N G Med J"},{"key":"5233_CR41","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1186\/s12936-017-2077-4","volume":"16","author":"E Lufele","year":"2017","unstructured":"Lufele E, Umbers A, Ordi J, Ome-Kaius M, Wangnapi R, Unger H, et al. Risk factors and pregnancy outcomes associated with placental malaria in a prospective cohort of Papua New Guinean women. Malar J. 2017;16:427.","journal-title":"Malar J"},{"key":"5233_CR42","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/1742-4755-10-46","volume":"10","author":"S Kura","year":"2013","unstructured":"Kura S, Vince J, Crouch-Chivers P. Male involvement in sexual and reproductive health in the Mendi district, Southern Highlands province of Papua New Guinea: a descriptive study. Reprod Health. 2013;10:46.","journal-title":"Reprod Health"},{"key":"5233_CR43","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1016\/j.midw.2013.03.011","volume":"29","author":"LM Vallely","year":"2013","unstructured":"Vallely LM, Homiehombo P, Kelly AM, Vallely A, Homer CS, Whittaker A. Exploring women\u2019s perspectives of access to care during pregnancy and childbirth: a qualitative study from rural Papua New Guinea. Midwifery. 2013;29:1222\u20139.","journal-title":"Midwifery"},{"key":"5233_CR44","unstructured":"Pascoe S. Community Engagement Toolkit: Milne Bay Provincial Health Authority, Papua New Guinea. 2016."},{"key":"5233_CR45","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1007\/s11135-017-0574-8","volume":"52","author":"B Saunders","year":"2018","unstructured":"Saunders B, Sim J, Kingstone T, Baker S, Waterfield J, Bartlam B, et al. Saturation in qualitative research: exploring its conceptualization and operationalization. Qual Quant. 2018;52:1893\u2013907.","journal-title":"Qual Quant"},{"key":"5233_CR46","volume-title":"Research methods in anthropology: qualitative and quantitative approaches","author":"H Bernard","year":"2006","unstructured":"Bernard H. Research methods in anthropology: qualitative and quantitative approaches. Oxford: Alta Mira Press; 2006."},{"key":"5233_CR47","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1016\/S0140-6736(22)02535-1","volume":"401","author":"M Madanitsa","year":"2023","unstructured":"Madanitsa M, Barsosio HC, Minja DTR, Mtove G, Kavishe RA, Dodd J, et al. Effect of monthly intermittent preventive treatment with dihydroartemisinin-piperaquine with and without azithromycin versus monthly sulfadoxine-pyrimethamine on adverse pregnancy outcomes in Africa: a double-blind randomised, partly placebo-controlled trial. Lancet. 2023;401:1020\u201336.","journal-title":"Lancet"},{"key":"5233_CR48","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1016\/S0140-6736(20)30552-3","volume":"395","author":"RW van der Pluijm","year":"2020","unstructured":"van der Pluijm RW, Tripura R, Hoglund RM, Pyae Phyo A, Lek D, Ul Islam A, et al. Triple artemisinin-based combination therapies versus artemisinin-based combination therapies for uncomplicated Plasmodium falciparum malaria: a multicentre, open-label, randomised clinical trial. Lancet. 2020;395:1345\u201360.","journal-title":"Lancet"},{"key":"5233_CR49","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1023\/A:1012050931018","volume":"23","author":"AB Overgaard","year":"2001","unstructured":"Overgaard AB, H\u00f8jsted J, Hansen R, M\u00f8ller-Sonnergaard J, Christrup LL. Patients\u2019 evaluation of shape, size and colour of solid dosage forms. Pharm World Sci. 2001;23:185\u20138.","journal-title":"Pharm World Sci"},{"key":"5233_CR50","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/s12936-023-04578-3","volume":"22","author":"A Rahmalia","year":"2023","unstructured":"Rahmalia A, Poespoprodjo JR, Landuwulang CUR, Ronse M, Kenangalem E, Burdam FH, et al. Adherence to 14-day radical cure for Plasmodium vivax malaria in Papua, Indonesia: a mixed-methods study. Malar J. 2023;22:162.","journal-title":"Malar J"},{"key":"5233_CR51","first-page":"CD009568","volume":"12","author":"S B\u00e9lard","year":"2020","unstructured":"B\u00e9lard S, Ramharter M, Kurth F. Paediatric formulations of artemisinin-based combination therapies for treating uncomplicated malaria in children. Cochrane Database Syst Rev. 2020;12:CD009568.","journal-title":"Cochrane Database Syst Rev"},{"key":"5233_CR52","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1186\/1475-2875-13-432","volume":"13","author":"C Pell","year":"2014","unstructured":"Pell C, Me\u00f1aca A, Chatio S, Hodgson A, Tagbor H, Pool R. The acceptability of intermittent screening and treatment versus intermittent preventive treatment during pregnancy: results from a qualitative study in Northern Ghana. Malar J. 2014;13:432.","journal-title":"Malar J"},{"key":"5233_CR53","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1186\/s12936-016-1627-5","volume":"15","author":"D Almond","year":"2016","unstructured":"Almond D, Madanitsa M, Mwapasa V, Kalilani-Phiri L, Webster J, ter Kuile F, et al. Provider and user acceptability of intermittent screening and treatment for the control of malaria in pregnancy in Malawi. Malar J. 2016;15:574.","journal-title":"Malar J"},{"key":"5233_CR54","doi-asserted-by":"publisher","first-page":"235","DOI":"10.3390\/tropicalmed8040235","volume":"8","author":"JA Cardona-Arias","year":"2023","unstructured":"Cardona-Arias JA. Synthesis of qualitative evidence on malaria in pregnancy, 2005\u20132022: a systematic review. Trop Med Infect Dis. 2023;8:235.","journal-title":"Trop Med Infect Dis"},{"key":"5233_CR55","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/1475-2875-9-18","volume":"9","author":"LA Smith","year":"2010","unstructured":"Smith LA, Jones C, Adjei RO, Antwi GD, Afrah NA, Greenwood B, et al. Intermittent screening and treatment versus intermittent preventive treatment of malaria in pregnancy: user acceptability. Malar J. 2010;9:18.","journal-title":"Malar J"}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-024-05233-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12936-024-05233-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-024-05233-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,13]],"date-time":"2025-01-13T21:47:26Z","timestamp":1736804846000},"score":1,"resource":{"primary":{"URL":"https:\/\/malariajournal.biomedcentral.com\/articles\/10.1186\/s12936-024-05233-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,13]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5233"],"URL":"https:\/\/doi.org\/10.1186\/s12936-024-05233-1","relation":{},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,13]]},"assertion":[{"value":"24 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approvals for this study were obtained from the Charles Darwin University Human Research Ethics Committee (H22094), the Human Research Committee of the Northern Territory Department of Health and Menzies School of Health Research (2021-4107), the PNG IMR Institutional Review Board (2113), the Madang Provincial Health Authority Research Ethics Committee (04.21), and Medical Research Advisory Committee of PNG National Department of Health (22.10). All participants provided written informed consent for this study. Women involved in the parent trial also provided written informed consent, independent of participation in the clinical trial. Methods used in participants recruitment, data collection, storage, processing, and analysis were carried out according to the Declaration of Helsinki, the Principles of Good Clinical Practice and PNG regulatory guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"13"}}